Evolus Q3 revenue rises 13% to $78.0 million; full-year revenue guidance reaffirmed
Evolus reported third-quarter 2026 net revenue of $78.0 million, up 13% from a year earlier, and a GAAP operating loss of $8.4 million, narrowed from $11.5 million. The company reaffirmed its full-year 2026 net revenue outlook of $330 million to $337 million, while still reporting a net loss of $12.5 million for the quarter.
Key points
- Q3 2026 net revenue of $78.0 million, up 13% from $69.0 million in Q3 2025
- Adjusted EBITDA of $1.2 million, compared with a loss of $3.1 million in Q3 2025
- Full-year 2026 net revenue guidance of $330 million to $337 million reaffirmed; non-GAAP operating expense guidance updated to $210 million to $213 million from $212 million to $216 million
- Cash and cash equivalents of $41.7 million as of September 30, 2026, versus $45.2 million at June 30, 2026
The filing
Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 04, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.